MIGLIACCIO RAFFAELE has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are ATADJA PETER WISDOM, NLS 1 PHARMA AG and LIMBURG HANS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 1 | |
#5 | Hong Kong | 1 | |
#6 | Israel | 1 | |
#7 | Taiwan | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Migliaccio Raffaele | 13 |
#2 | Sardei Antonella | 13 |
#3 | Migliaccio Carmela | 13 |
Publication | Filing date | Title |
---|---|---|
CA2986371A1 | Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases | |
EP3215143A1 | Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions | |
EP3177281A1 | Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies |